Screener
Quest Diagnostics DGX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Equity in earnings of equity method investees, net of taxes | 10 | 9 | 14 | 27 |
| Net income | 334 | 296 | 598 | 531 |
| Less: Net income attributable to noncontrolling interests | 14 | 14 | 26 | 29 |
| Net income attributable to Quest Diagnostics | $320 | $282 | $572 | $502 |
| Earnings per share attributable to Quest Diagnostics’ common stockholders: | ||||
| Basic | $2.88 | $2.51 | $5.15 | $4.48 |
| Diluted | $2.84 | $2.47 | $5.08 | $4.41 |
| Weighted average common shares outstanding: |
Cover / Front Matter
FAQ
- What is Quest Diagnostics's net income?
- Quest Diagnostics (DGX) reported net income of $320M in Q2 2026.
- How has Quest Diagnostics's net income changed year-over-year?
- Quest Diagnostics's net income increased by 13.5% year-over-year, from $282M to $320M.
- What is the long-term trend for Quest Diagnostics's net income?
- Over 4 years (2021 to 2025), Quest Diagnostics's net income has grown at a -16.0% compound annual growth rate (CAGR), from $2B to $992M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Quest Diagnostics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude